Koudai Kani

Imizu, 9390398, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Strain-Dependent Effects of Dietary Cholic Acid on Liver Fibrogenesis and Gut Microbiota in TSNO and TSOD Mice.

Strain-Dependent Effects of Dietary Cholic Acid on Liver Fibrogenesis and Gut Microbiota in TSNO and TSOD Mice.

Journal: Biomedicines
Published: December 19, 2025

Cholic Acid-Induced Akkermansia Expansion and FGF-15 Upregulation Improve Diabetes While Exacerbating Steatohepatitis in TSOD Mice.

Cholic Acid-Induced Akkermansia Expansion and FGF-15 Upregulation Improve Diabetes While Exacerbating Steatohepatitis in TSOD Mice.

Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: June 18, 2025

Critical Role of Cholic Acid in the Development of iHFC Diet-induced MASH in TSNO Mice.

Critical Role of Cholic Acid in the Development of iHFC Diet-induced MASH in TSNO Mice.

Journal: Inflammation
Published: January 23, 2025

Rice Kefiran Ameliorates Obesity and Hepatic Steatosis Through the Change in Gut Microbiota.

Rice Kefiran Ameliorates Obesity and Hepatic Steatosis Through the Change in Gut Microbiota.

Journal: Microorganisms
Published: November 22, 2024

Antibiotic effects on gut microbiota modulate diet-induced metabolic dysfunction-associated steatohepatitis development in C57BL/6 mice.

Antibiotic effects on gut microbiota modulate diet-induced metabolic dysfunction-associated steatohepatitis development in C57BL/6 mice.

Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: April 19, 2024

Impacts of liver macrophages, gut microbiota, and bile acid metabolism on the differences in iHFC diet-induced MASH progression between TSNO and TSOD mice.

Impacts of liver macrophages, gut microbiota, and bile acid metabolism on the differences in iHFC diet-induced MASH progression between TSNO and TSOD mice.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: January 18, 2024

Isoliquiritigenin inhibits NLRP3 inflammasome activation with CAPS mutations by suppressing caspase-1 activation and mutated NLRP3 aggregation.

Isoliquiritigenin inhibits NLRP3 inflammasome activation with CAPS mutations by suppressing caspase-1 activation and mutated NLRP3 aggregation.

Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: December 05, 2023

Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice.

Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice.

Journal: Biomedicines
Published: September 01, 2023

The innate immune receptor RP105 promotes metabolic syndrome by altering gut microbiota composition and intestinal barrier function.

The innate immune receptor RP105 promotes metabolic syndrome by altering gut microbiota composition and intestinal barrier function.

Journal: Biochemical and biophysical research communications
Published: April 14, 2023

Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice.

Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice.

Journal: International journal of molecular sciences
Published: December 29, 2022

Roles of Macrophages in Advanced Liver Fibrosis, Identified Using a Newly Established Mouse Model of Diet-Induced Non-Alcoholic Steatohepatitis.

Roles of Macrophages in Advanced Liver Fibrosis, Identified Using a Newly Established Mouse Model of Diet-Induced Non-Alcoholic Steatohepatitis.

Journal: International journal of molecular sciences
Published: October 07, 2022
Showing 1-11 of 11

Last Updated: 09/26/2026